Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KNX vs GSK✓SelectedUSD · GSKKNX vs GSK performance historyLatest closeAs of+0.67%11/18
Stock and ETF performance explorer

KNX vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+15.0%
GSK return
+42.7%
Excess return
-27.6%
Maximum drawdown
-38.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.7%-1.3%+2.0%+0.9%
7D+0.5%-3.1%+3.7%+1.0%
30D-0.8%-0.9%+0.1%-0.6%
3M-11.1%-4.2%-6.9%-10.5%
6M-9.0%-1.6%-7.4%-8.9%
YTD+21.0%+2.6%+18.4%+20.2%
1Y+51.4%+6.2%+45.2%+49.7%
3Y+26.7%+55.0%-28.3%+14.2%
5Y+15.0%+42.8%-27.8%+3.0%
All+15.0%+42.7%-27.6%+3.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling